— Know what they know.
Not Investment Advice

RPID NASDAQ

Rapid Micro Biosystems, Inc.
1W: -17.1% 1M: -33.8% 3M: -48.0% YTD: -70.7% 1Y: -73.4% 3Y: -11.5% 5Y: -95.0%
$0.92
-0.00 (-0.11%)
 
Weekly Expected Move ±7.3%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Medical - Devices · Tech Score Strong Sell · Power 33 · $41.7M mcap · 26M float · 0.886% daily turnover · Short 48% of daily vol

Cash Flow Trends

Operating Cash Flow
-$31M +29.6% ▲
Capital Expenditures
$850K +37.7% ▲
5Y CAGR: +4.3%
Free Cash Flow
-$32M +29.9% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$3M +141.2% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income-$74M-$61M-$52M-$47M-$47M
Depreciation & Amort.$2M$3M$3M$3M$3M
Stock-Based Comp.$2M$4M$5M$0$4M
Change in Working Capital-$8M-$5M$555K-$5M$6M
Other Non-Cash Items$23M$728K-$1M$4M$3M
Operating Cash Flow-$55M-$59M-$45M-$44M-$31M
— Investing Activities —
Capital Expenditures-$3M-$7M-$2M-$1M-$850K
Acquisitions (Net)$0$0$0$0$0
Investment Purchases-$25M-$179M-$62M-$35M-$27M
Investment Sales$15M$92M$106M$73M$42M
Other Investing$20K$0$0$0$0
Investing Cash Flow-$13M-$93M$42M$37M$14M
— Financing Activities —
Net Debt Issuance-$26M-$33K-$37K-$35K$19M
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing-$940K$726K$186K$0-$419K
Financing Cash Flow$217M$693K$149K$203K$20M
Net Change in Cash$148M-$151M-$3M-$7M$3M
Cash End of Period$179M$27M$25M$17M$20M
Free Cash Flow-$58M-$65M-$47M-$46M-$32M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms